| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $867.0M | +10.6% |
| Cost of Revenue | $152.7M | +20.6% |
| Gross Profit | $714.3M | +8.7% |
| R&D Expense | $227.3M | +19.4% |
| SG&A Expense | $151.6M | -58.8% |
| Operating Income | -$211.8M | +12.1% |
| Interest Expense | $18.2M | +64.3% |
| Pre-tax Income | -$225.0M | +8.3% |
| Income Tax | $27.2M | +611.9% |
| Net Income | -$252.2M | -1.2% |
| EPS (Basic) | -$1.82 | +30.0% |
| EPS (Diluted) | -$1.82 | +30.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $197.0M | -3.1% |
| Accounts Receivable | $10.7M | +34.9% |
| Current Assets | $327.9M | -4.1% |
| Total Assets | $730.5M | -18.8% |
| Current Liabilities | $438.2M | +19.3% |
| Long-term Debt | $473.2M | -7.8% |
| Total Liabilities | $1.03B | +13.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $164.2M | +33.3% |
| Capital Expenditures | $11.5M | +4.7% |
| Investing Cash Flow | -$12.0M | +94.2% |
| Financing Cash Flow | -$152.8M | -158.6% |
| Free Cash Flow | $152.7M | +36.2% |
| Stockholders' Equity |
| -$303.0M |
| -2147.9% |